Lipocine financial statements

리포신NASDAQ:LPCN · Nasdaq · Healthcare · sector #16
$2.10+1.45%
2026-10-06 close · prelim

Lipocine's published financial data is dated 2026-10-04. 2024 revenue was $11M. 2024 operating profit was −$1M.

Reported results

Lipocine notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q